Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Neurol 97:e1367-e1381, Gaig, C.,et al, 2021
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
Fisher Syndrome after Campylobacter Jejuni Enteritis:Human Leukocyte Antigen and the Bacterial Serotype
J Pediatr 126:55-57, Yuki,N.,et al, 1995
Human Leukocyte Antigens in Fisher's Syndrome
Ann Neurol 33:655-657, Yuki,N.,et al, 1993
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976